FirmaIQ
Org.nr 992 709 014 2019 → 2020 Year-over-year analysis

3P BIOTECH NORWAY AS: årsregnskap 2020 vs 2019

Grew 20% on revenue, cash halved-plus

approved 2021-04-20; registry 2021-05-01; journal 2021 245171

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2020 with 2019 for 3P BIOTECH NORWAY AS. Revenue 80.7k NOK → 96.4k NOK (+19.5%). Net result +4 NOK → +3 624 NOK. Equity 393.2k NOK → 396.9k NOK.

On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: cash fell.

Also worth watching: cogs fell. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.

At a glance

Scorecard

Revenue
80.7k NOK 96.4k NOK
+19.5%
Operating result
+18.3k NOK +34.3k NOK
+88.1%
Net result
+4 NOK +3 624 NOK
+90500.0%
Equity
393.2k NOK 396.9k NOK
+0.9%
Cash
6 409 NOK 1 691 NOK
-73.6%
Total assets
2.33m NOK n/m
—

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 80.7k NOK to 96.4k NOK (+19.5% YoY). Calculated

  • ↑

    Operating result improved

    Operating result +18.3k NOK → +34.3k NOK (op. margin 22.6% → 35.6%). Calculated

  • ↑

    Net result improved

    Net result +4 NOK → +3 624 NOK (net margin 0.0% → 3.8%). Calculated

  • ↑

    Equity strengthened

    Book equity 393.2k NOK → 396.9k NOK. Calculated

What deteriorated

  • ↓

    Cash fell

    Bank deposits 6 409 NOK → 1 691 NOK (-73.6% YoY). Calculated

Things to notice

  • ·

    COGS fell

    COGS / varekostnad 32.1k NOK → 6 389 NOK (-80.1% YoY). Calculated